Neurology > > General Neurology– News and commentary from the world of neurology and neuroscience
by Judy George, Deputy Managing Editor, MedPage Today March 12, 2024
More information supported links in between the impotence drug sildenafil (Viagra) and decreased Alzheimer's danger. (Journal of Alzheimer's Disease
The American Headache Society provided an agreement position declaration stating drugs targeting calcitonin gene-related peptide are a first-line choice for migraine avoidance. (Headache
Eli Lilly stated the FDA will hold an advisory committee conference to go over the stage III TRAILBLAZER-ALZ 2 trial of investigational donanemab in early symptomatic Alzheimer's illness.
Glial fibrillary acid protein and neurofilament heavy chain in cerebrospinal fluid were related to non-relapsing MS. (JAMA Neurology
A just recently authorized mix of salt phenylbutyrate and taurursodiol (Relyvrio) did not fulfill its main endpoint in a confirmatory amyotrophic lateral sclerosis trial, Amylyx Pharmaceuticals stated. The business might pull the drug from the marketplace.
Cysticercosis– infection brought on by tapeworm larvae– provided as migraine in a 52-year-old male. (American Journal of Case Reports
Merck KGaA dropped its investigational Bruton's tyrosine kinase (BTK) inhibitor evobrutinib after the drug stopped working to beat teriflunomide (Aubagio) in 2 stage III trials of numerous sclerosis. (Strong Biotech
The FDA upgraded its draft assistance for establishing drugs to deal with early Alzheimer's illness to consist of the company's present thinking of biomarkers in medical trials.
Practical MRI demonstrated how the brain concentrated on focusing while filtering interruption. (Nature Human Behavior
Almost half of clients who utilized marijuana to handle migraine stated it added to utilizing less migraine medication. (Neurology
-
Judy George covers neurology and neuroscience news for MedPage Today, discussing brain aging, Alzheimer's, dementia, MS, unusual illness, epilepsy, autism, headache, stroke, Parkinson's, ALS, concussion, CTE, sleep, discomfort, and more. Follow
